NASDAQ$CVRX

CVRx Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

CVRx reported an impressive quarter, driven by U.S. heart failure business growth and continued execution of commercial strategy.

CVRx reported an 89% increase in revenue to $9.5 million for Q2 2023, driven by a 111% increase in U.S. revenue. Gross profit increased by 108% to $8.0 million, with a gross margin of 84%. Net loss was $11.7 million, or $0.56 per share.

  • Revenue increased by 89% to $9.5 million compared to the prior year quarter.
  • U.S. revenue increased by 111% to $8.3 million compared to the prior year quarter.
  • Gross profit increased by 108% to $8.0 million with gross margin at 84%.
  • The number of sales territories in the U.S. increased by three to a total of 32.

Headline financials

Total Revenue

$9.5M

Previous: $5.03M+88.8%
EPS (adj)

-$0.56

Previous: -$0.54-3.7%
Active Implanting Centers in U.S.

140

Previous: 71+97.2%
U.S. Revenue Units

265

Previous: 128+107.0%
Capital Expenditures

-$383K

Previous: -$342K-12.0%
Free Cash Flow

-$12M

Previous: -$11.4M-5.4%
Net Income

-$11.7M

Previous: -$11.1M-5.2%
Operating Income

-$11.8M

Previous: -$11M-6.7%
Gross Profit

$7.98M

Previous: $3.83M+108.4%
Cash & Equivalents

$90.8M

Previous: $121M-25.2%
Total Assets

$115M

Previous: $134M-14.2%
Stock-Based Comp

$1.48M

Previous: $1.1M+34.2%

Revenue & EPS history

CVRx · Revenue · Quarterly

$9.5M

Q2 2023+88.8%vs Q2 2022
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Forward guidance

The Company expects to report total revenue between $9.5 million and $10.2 million for the third quarter of 2023.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-0.9%

Avg return

Earnings day

-0.4%

Avg return

5 days after

-1.6%

Avg return

30 days after

48%

10 / 21 earnings

Positive

+36.7%

Q3 2024

Best reaction

-39.0%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-6.7%-13.3%-29.2%
Q4 2025-13.0%-14.8%+32.3%
Q3 2025+0.8%-3.4%-8.5%
Q1 2025-39.0%-32.0%-15.7%
Q4 2024-7.2%-8.4%-28.8%
Q3 2024+36.7%+30.2%+48.8%
Q2 2024-17.5%-14.4%+3.3%
Q1 2024-33.8%-39.7%-55.0%
Q4 2023-1.4%-6.1%-19.6%
Q3 2023-1.2%+0.5%+50.4%
Q2 2023+6.2%+5.7%+2.3%
Q1 2023+24.0%+34.2%+41.1%
Q4 2022+3.1%+5.9%-24.2%
Q3 2022+2.7%+21.4%+43.1%
Q2 2022+22.1%+24.6%+4.6%
Q1 2021-3.4%-12.0%-6.3%
Q1 2022+12.6%+28.5%+14.0%
Q4 2021+0.9%+0.0%-21.2%
Q3 2021+4.8%+4.1%-36.5%
Q2 2020-4.7%-13.0%-13.0%
Q2 2021-5.6%-7.5%-15.8%
Q4 2020
Q3 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro